Orchestra BioMed Holdings (OBIO) Receivables: 2022-2025
Historic Receivables for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Sep 2025 value amounting to $52,000.
- Orchestra BioMed Holdings' Receivables fell 54.78% to $52,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $316,000, marking a year-over-year decrease of 12.47%. This contributed to the annual value of $92,000 for FY2024, which is 7.07% down from last year.
- Latest data reveals that Orchestra BioMed Holdings reported Receivables of $52,000 as of Q3 2025, which was down 37.35% from $83,000 recorded in Q2 2025.
- In the past 5 years, Orchestra BioMed Holdings' Receivables registered a high of $171,000 during Q2 2023, and its lowest value of $52,000 during Q3 2025.
- Over the past 3 years, Orchestra BioMed Holdings' median Receivables value was $86,000 (recorded in 2023), while the average stood at $91,818.
- In the last 5 years, Orchestra BioMed Holdings' Receivables surged by 33.72% in 2024 and then slumped by 54.78% in 2025.
- Quarterly analysis of 4 years shows Orchestra BioMed Holdings' Receivables stood at $96,000 in 2022, then grew by 3.12% to $99,000 in 2023, then declined by 7.07% to $92,000 in 2024, then tumbled by 54.78% to $52,000 in 2025.
- Its Receivables was $52,000 in Q3 2025, compared to $83,000 in Q2 2025 and $89,000 in Q1 2025.